# Bausch Health completes acquisition of DURECT

Bausch Health Companies completed its acquisition of DURECT Corporation on September 11, 2025, after a tender offer. DURECT shareholders received $1.75 per share in cash plus contingent value rights tied to net sales milestones.

- Type: Acquisition
- Announced: 2025-09-11
- Where: United States
- Status: completed
- Products: pharmaceutical products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bausch Health Companies](https://endata.com/companies/35454.md) (acquirer)
- [DURECT Corporation](https://endata.com/companies/87206.md) (target)

## Sources

- [aibio.space](https://aibio.space/news/bausch-health-completes-durect-acquisition-after-tender-offer-draws/), 2025-09-11: "Bausch Health Companies Inc. (NYSE: BHC) has completed its acquisition of DURECT Corporation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.